Harnessing Annexin V's properties to address clinical needs
Research led by Dr. Francis Blankenberg at Stanford University provides applications for Annexin V, a protein known for its high affinity for phosphatidylserine (PS), including cancer therapy, bacteriophage stabilization, infection control, early cancer detection, and in vivo imaging of cell death.